Skip to content
DeepViews

NewGenIvf Group Limited Class A ordinary shares (NIVF) — Analysis Summary

NewGenIvf Group Limited Class A ordinary shares (NIVF) has a market cap of $3.00M with year-over-year revenue growth of -13.0%. Net margin stands at 209.0%. The stock trades at a P/E ratio of 0.3.

Key Takeaways

  • Revenue changed -13.0% year-over-year
  • Net margin of 209.0%
  • P/E ratio of 0.3

Compared with its sector, NIVF posted revenue growth of -13.0% and trades at a P/E of 0.3.

[XNAS]

NewGenIvf Group Limited Class A ordinary shares (NIVF)

$0.42

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$3.00M
Enterprise Value
$6.34M
P/E Ratio
0.3
Div Yield
0.00%
EV/EBITDA
-0.6
Company Profile
About
About NewGenIvf Group Limited Class A ordinary shares

NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.

Employees

87

Exchange

XNAS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
25
No Moat

Systematic competitive advantage assessment based on 3yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$25.99M
Total Debt$4.10M
Debt-to-Equity0.16
Cash & Equivalents$0.76M

Cash Flow

Operating Cash Flow$-10.93M
Free Cash Flow$-11.06M
FCF Margin-234.03%
P/FCF Ratio-0.27
Source: Polygon.io · SEC EDGAR
Dividends
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.